GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

Stock Information for GT Biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GT Biopharma Inc.

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials
GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.